SE442301B - Sett att framstella deaminoderivat av kallikrein-trypsin-inhibitor fran notorgan - Google Patents

Sett att framstella deaminoderivat av kallikrein-trypsin-inhibitor fran notorgan

Info

Publication number
SE442301B
SE442301B SE7704928A SE7704928A SE442301B SE 442301 B SE442301 B SE 442301B SE 7704928 A SE7704928 A SE 7704928A SE 7704928 A SE7704928 A SE 7704928A SE 442301 B SE442301 B SE 442301B
Authority
SE
Sweden
Prior art keywords
callicrein
organ
trypsin inhibitor
diamino derivatives
prepare
Prior art date
Application number
SE7704928A
Other languages
English (en)
Swedish (sv)
Other versions
SE7704928L (sv
Inventor
E Schnabel
H D Schlumberger
G Reinhardt
E Truscheit
H Tschesche
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE7704928L publication Critical patent/SE7704928L/xx
Publication of SE442301B publication Critical patent/SE442301B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE7704928A 1976-04-30 1977-04-28 Sett att framstella deaminoderivat av kallikrein-trypsin-inhibitor fran notorgan SE442301B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762619246 DE2619246A1 (de) 1976-04-30 1976-04-30 Desamino-derivate des kallikrein- trypsin-inhibitors, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
SE7704928L SE7704928L (sv) 1977-10-31
SE442301B true SE442301B (sv) 1985-12-16

Family

ID=5976820

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7704928A SE442301B (sv) 1976-04-30 1977-04-28 Sett att framstella deaminoderivat av kallikrein-trypsin-inhibitor fran notorgan

Country Status (11)

Country Link
US (1) US4118481A (Direct)
JP (1) JPS52134009A (Direct)
AT (1) AT361118B (Direct)
BE (1) BE854102A (Direct)
CH (1) CH635514A5 (Direct)
DE (1) DE2619246A1 (Direct)
DK (1) DK188077A (Direct)
FR (1) FR2349598A1 (Direct)
GB (1) GB1533358A (Direct)
NL (1) NL7704690A (Direct)
SE (1) SE442301B (Direct)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748294A1 (de) * 1977-10-27 1979-05-03 Bayer Ag Neue derivate des bpti, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2748295A1 (de) * 1977-10-27 1979-05-03 Bayer Ag Neue derivate des bpti
US4997537A (en) * 1986-10-21 1991-03-05 Northeastern University High performance microcapillary gel electrophoresis
US5665216A (en) * 1986-10-21 1997-09-09 Northeastern University Capillary column for high performance electrophoretic separation and detection of SDS proteins and system and using the same
ATE275583T1 (de) * 1994-01-11 2004-09-15 Dyax Corp KALLIKREINHEMMENDE ßKUNITZ-DOMÄNEß-PROTEINE UND DERIVATEN DAVON
ES2375561T3 (es) * 1994-01-11 2012-03-02 Dyax Corporation Inhibidores de la plasmina humana derivados de dominios kunitz y �?cidos nucleicos que codifican los mismos.
US6057287A (en) * 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US20040054082A1 (en) * 2001-12-03 2004-03-18 Bank David H Toughened polymer blends with improved surface properties
ES2528254T3 (es) 2002-06-07 2015-02-05 Dyax Corp. Polipéptidos de dominio Kunitz modificado y su uso para reducir la isquemia o el inicio de una respuesta inflamatoria sistémica asociada con un procedimiento quirúrgico
US7153829B2 (en) * 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
DK1542710T3 (da) 2002-08-28 2012-10-15 Dyax Corp Fremgangsmåde til konservering af organer og væv
US7235530B2 (en) * 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
US7276480B1 (en) 2005-12-30 2007-10-02 Dyax Corp. Prevention and reduction of blood loss
JP2009529542A (ja) * 2006-03-10 2009-08-20 ダイアックス コーポレーション エカランチドに関する配合物
JP2010536870A (ja) * 2007-08-21 2010-12-02 ジェンザイム・コーポレーション カリクレイン阻害剤を用いた治療
WO2009026539A1 (en) * 2007-08-23 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
WO2010080833A1 (en) * 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
HRP20220107T1 (hr) 2010-01-06 2022-04-15 Takeda Pharmaceutical Company Limited Proteini koji vežu kalikrein plazme
KR102107695B1 (ko) 2011-01-06 2020-05-07 다이액스 코포레이션 혈장 칼리크레인 결합 단백질
CA2942713A1 (en) 2014-03-27 2015-10-01 Dyax Corp. Compositions and methods for treatment of diabetic macular edema
EP3387018A1 (en) 2015-12-11 2018-10-17 Dyax Corp. Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
AU2021209045A1 (en) 2020-01-13 2022-07-28 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack

Also Published As

Publication number Publication date
AT361118B (de) 1981-02-25
FR2349598B1 (Direct) 1980-02-22
SE7704928L (sv) 1977-10-31
GB1533358A (en) 1978-11-22
US4118481A (en) 1978-10-03
FR2349598A1 (fr) 1977-11-25
NL7704690A (nl) 1977-11-01
JPS52134009A (en) 1977-11-09
CH635514A5 (de) 1983-04-15
DK188077A (da) 1977-10-31
DE2619246A1 (de) 1977-11-10
BE854102A (fr) 1977-10-31
ATA305477A (de) 1980-07-15

Similar Documents

Publication Publication Date Title
SE442301B (sv) Sett att framstella deaminoderivat av kallikrein-trypsin-inhibitor fran notorgan
SE7607771L (sv) Sett for framstellning av utvidgningsbara perlor
SE420599B (sv) Sett att framstella farmakologiskt aktiva derivat av 4-hydroxi-2-pyrrolidon
SE439485B (sv) Sett att framstella nya alkyloximderivat av 7-aminotiazolyl-acetamidocefalosporansyra
SE7707624L (sv) Sett att tillverka gasbemenghda sotsaker
SE429551B (sv) Sett att framstella 1-(3-dimetylamino-propyl)-ftalanderivat
SE426940B (sv) Sett for att inhibera avsettning av pannsten fran vatten
SE7709278L (sv) Sett for framstellning av polyuretankarbamider
SE422730B (sv) Sett att oka avkastningen vid knolproducerande vexter
SE428173B (sv) Sett att framstella pour-on-beredningar av 2,3,5,6-tetrahydro-6-fenyl-imidazol-(2,1-6)tiazol
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE440087B (sv) Sett for avsvavling av jernsmeltor
SE7601778L (sv) Framstellning av vete
SE7608799L (sv) Sett att framstella kromanon-(4)
SE7800526L (sv) Sett att skilja blandningar av i varandra olosliga vetskor
SE7801649L (sv) Sett att framstella nya trifluormetyl-oligopeptidderivat av l-alanin
NO781041L (no) Nuklidgenerator til fremstilling av radionuklider
SE7802834L (sv) Sett att framstella nya oximderivat av 7-amino--tiazolyl-acetamidocefalosporansyra
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE7603359L (sv) Sett for direkt framstellning av rastal
SE432726B (sv) Sett att tillverka en keramisk form for noggrann formning av en gjuten produkt
SE432926B (sv) Sett att framstella disubstituerade fenoletrar av 3-amino-2-hydroxipropan
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE7601061L (sv) Sett for avskalning av aluminidoverdrag
SE7607138L (sv) Dl- och 8r-9-fluorprostadiensyraderivat och sett att framstella desamma

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7704928-6

Effective date: 19880822

Format of ref document f/p: F